This anticipated erosion in net worth, which the lender estimated at 2.35% of the total, follows Monday’s disclosures on discrepancies in derivative deals over the past five to seven years, executives told analysts in a late-evening call.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO